Atea Pharmaceuticals, Inc.

Q4 2020 13F Holders

Symbol
AVIR
CUSIP
04683R106
Type
Equity
Class
COM
Num filings
70
Total reported value, excl. options
$2.07 B
Manager Report Date Value ($000) Shares Option Type